|

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

RECRUITINGPhase 4Sponsored by Memorial Sloan Kettering Cancer Center
Actively Recruiting
PhasePhase 4
SponsorMemorial Sloan Kettering Cancer Center
Started2025-12-16
Est. completion2027-12-16
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →

NCT07308717

Summary

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 18 to 65 years
* Undergoing ambulatory extended recover (AXR) mastectomy (bilateral or unilateral) at the Josie Robertson Surgical Center (JSRC)

Exclusion Criteria:

* None

Conditions2

Breast CancerCancer

Locations7 sites

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, 07920
James Flory, MD646-608-2684
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown, New Jersey, 07748
James Flory, MD646-608-2684
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, 07645
James Flory, MD646-608-2684
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)
Commack, New York, 11725
James Flory, MD646-608-2684
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, 10604
James Flory, MD646-608-2684

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.